Second effective vaccine fuels rally, Tesla joins S&P

Dominating headlines yesterday was the news that Moderna’s Covid-19 vaccine has proven 94.5% effective in a late-stage trial, a week after Pfizer reported similar results in its own trial. More data is expected from the study later this month, and Moderna said that it plans to ask health authorities to clear the vaccine by earlyContinue reading “Second effective vaccine fuels rally, Tesla joins S&P”

Create your website with WordPress.com
Get started